Login / Signup

Large-scale evaluation of the ability of RNA-binding proteins to activate exon inclusion.

Jonathan C SchmokManya JainLena Annika StreetAlex T TankkaDanielle SchaferHsuan-Lin HerSara ElmsaouriMaya L GosztylaEvan A BoylePratibha JagannathaEn-Ching LuoEster J KwonMarko JovanovicGene W Yeo
Published in: Nature biotechnology (2024)
RNA-binding proteins (RBPs) modulate alternative splicing outcomes to determine isoform expression and cellular survival. To identify RBPs that directly drive alternative exon inclusion, we developed tethered function luciferase-based splicing reporters that provide rapid, scalable and robust readouts of exon inclusion changes and used these to evaluate 718 human RBPs. We performed enhanced cross-linking immunoprecipitation, RNA sequencing and affinity purification-mass spectrometry to investigate a subset of candidates with no prior association with splicing. Integrative analysis of these assays indicates surprising roles for TRNAU1AP, SCAF8 and RTCA in the modulation of hundreds of endogenous splicing events. We also leveraged our tethering assays and top candidates to identify potent and compact exon inclusion activation domains for splicing modulation applications. Using these identified domains, we engineered programmable fusion proteins that outperform current artificial splicing factors at manipulating inclusion of reporter and endogenous exons. This tethering approach characterizes the ability of RBPs to induce exon inclusion and yields new molecular parts for programmable splicing control.
Keyphrases
  • mass spectrometry
  • poor prognosis
  • endothelial cells
  • high throughput
  • type diabetes
  • transcription factor
  • long non coding rna
  • quantum dots
  • ms ms
  • liquid chromatography
  • binding protein
  • network analysis